Brief: Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer
28/06/2023 13:06
June 28 (Reuters) - Ovid Therapeutics Inc OVID.O :
* OVID THERAPEUTICS EXPANDS ITS SCIENTIFIC LEADERSHIP TEAM &
APPOINTS CHIEF STRATEGY OFFICER
* OVID THERAPEUTICS INC - CONTINUES TO EXPECT THAT ITS
CAPITAL
SHOULD FUND OPERATIONS INTO FIRST HALF OF 2025
Source text for Eikon: ID:nGNXBPqR6
Further company coverage: OVID.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors